FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX)

Nihal M.; Wu J.; Wood G. S.

首页> 外文期刊>The Journal of investigative dermatology. >FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX)

【24h】

FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX)

机译：皮肤T细胞淋巴瘤（CTCL）中的Fas-配体（FASL）表达由启动子甲基化调节，可以通过甲氨蝶呤（MTX）进行DEREMETE

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of investigative dermatology.》 |2018年第19期|共1页
作者
Nihal M.; Wu J.; Wood G. S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX) [J] . Nihal M., Wu J., Wood G. S. The Journal of investigative dermatology. . 2018,第5a19期

机译：皮肤T细胞淋巴瘤（CTCL）中的Fas-配体（FASL）表达由启动子甲基化调节，可以通过甲氨蝶呤（MTX）进行DEREMETE
2. Mechanisms governing promoter methylation and apoptosis in cutaneous T-cell lymphoma: implications for therapy with methotrexate and JAK-inhibitors [J] . Nihal M., Wu J., Wood G. S. The Journal of investigative dermatology. . 2019,第5Suppla1期

机译：治疗皮肤T细胞淋巴瘤在皮肤T细胞淋巴瘤中的启动子甲基化和凋亡的机制：对甲氨蝶呤和JAK抑制剂治疗的影响
3. Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma [J] . JonesC.L., FerreiraS., McKenzieR.C.T., The Journal of investigative dermatology. . 2012,第8期

机译：在原发性皮肤T细胞淋巴瘤中通过启动子低甲基化调节T-plastin表达
4. INFLUENCE OF HYDROPHOBIC SURFACE MODIFICATION OF CHITOSAN BASED METHOTREXATE (MTX) MICRO IMPLANTS TO TREAT INTRAOCULAR LYMPHOMA [C] . Soumyarwit Manna, James J. Augsburger, Zelia M. Correa, ASME bioengineering conference . 2014

机译：壳聚糖基甲氨蝶呤（MTX）微植入物疏水表面改性对治疗眼内淋巴瘤的影响
5. Analysis of supernumerary clonal gamma T-cell receptor gene rearrangements in cutaneous T-cell lymphoma [D] . Tolpinrud, Whitney Lynn 2011

机译：皮肤T细胞淋巴瘤中叠加克隆γT细胞受体基因重排分析
6. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators [O] . Ivan V. Litvinov, Michael T. Tetzlaff, Philippe Thibault, 2017

机译：皮肤T细胞淋巴瘤（CTCL）中的基因表达分析突出了疾病的异质性以及潜在的诊断和预后指标
7. 160 Mechanisms governing promoter methylation and apoptosis in cutaneous T-cell lymphoma: implications for therapy with methotrexate and JAK-inhibitors [O] . M. Nihal, J. Wu, G.S. Wood 2019

机译：160机制治疗激素T细胞淋巴瘤中的启动子甲基化和凋亡：对甲氨蝶呤和jak抑制剂治疗的影响

FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX)

著录项

相似文献

相关主题

期刊订阅